Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis

Por te Brake, Lindsey H. M., Boeree, Martin J., Aarnoutse, Robert E.
Publicado no Am J Respir Crit Care Med (2019)

Rifampicin Transport by OATP1B1 Variants

Por Litjens, Carlijn H. C., van den Heuvel, Jeroen J. M. W, Russel, Frans G. M., Aarnoutse, Rob E., te Brake, Lindsey H. M., Koenderink, Jan B.
Publicado no Antimicrob Agents Chemother (2020)

Moxifloxacin Is a Potent In Vitro Inhibitor of OCT- and MATE-Mediated Transport of Metformin and Ethambutol

Por te Brake, Lindsey H. M., van den Heuvel, Jeroen J. M. W., Buaben, Aaron O., van Crevel, Reinout, Bilos, Albert, Russel, Frans G., Aarnoutse, Rob E., Koenderink, Jan B.
Publicado no Antimicrob Agents Chemother (2016)

Assessment of the Additional Value of Verapamil to a Moxifloxacin and Linezolid Combination Regimen in a Murine Tuberculosis Model

Por Pieterman, Elise D., te Brake, Lindsey H. M., de Knegt, Gerjo J., van der Meijden, Aart, Alffenaar, Jan-Willem C., Bax, Hannelore I., Aarnoutse, Rob E., de Steenwinkel, Jurriaan E. M.
Publicado no Antimicrob Agents Chemother (2018)

Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis Patients

Por te Brake, Lindsey H.M., Yunivita, Vycke, Livia, Resvi, Soetedjo, Nanny, van Ewijk‐Beneken Kolmer, Eleonora, Koenderink, Jan B., Burger, David M., Santoso, Prayudi, van Crevel, Reinout, Alisjahbana, Bachti, Aarnoutse, Rob E., Ruslami, Rovina
Publicado no Clin Pharmacol Ther (2018)

The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

Por Svensson, Elin M, Svensson, Robin J, te Brake, Lindsey H M, Boeree, Martin J, Heinrich, Norbert, Konsten, Sarah, Churchyard, Gavin, Dawson, Rodney, Diacon, Andreas H, Kibiki, Gibson S, Minja, Lilian T, Ntingiya, Nyanda E, Sanne, Ian, Gillespie, Stephen H, Hoelscher, Michael, Phillips, Patrick P J, Simonsson, Ulrika S H, Aarnoutse, Rob
Publicado no Clin Infect Dis (2018)

High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)

Por Marais, Suzaan, Cresswell, Fiona V, Hamers, Raph L., te Brake, Lindsey H.M., Ganiem, Ahmad R., Imran, Darma, Bangdiwala, Ananta, Martyn, Emily, Kasibante, John, Kagimu, Enock, Musubire, Abdu, Maharani, Kartika, Estiasari, Riwanti, Kusumaningrum, Ardiana, Kusumadjayanti, Nadytia, Yunivita, Vycke, Naidoo, Kogieleum, Lessells, Richard, Moosa, Yunus, Svensson, Elin M., Huppler Hullsiek, Katherine, Aarnoutse, Rob E., Boulware, David R., van Crevel, Reinout, Ruslami, Rovina, Meya, David B.
Publicado no Wellcome Open Res (2020)